Fluid biomarkers of white matter hyperintensities in cerebrovascular disease and neurodegeneration: a systematic review protocol
- PMID: 33993148
- DOI: 10.11124/JBIES-20-00210
Fluid biomarkers of white matter hyperintensities in cerebrovascular disease and neurodegeneration: a systematic review protocol
Abstract
Objective: The goal of this systematic review is to evaluate the association between fluid biomarkers and white matter hyperintensities (WMH) in cerebrovascular disease and neurodegenerative disorders. While previous research has examined the etiology of WMH in specific diseases, we propose a comprehensive framework encompassing WMH of both vascular and non-vascular origin.
Introduction: Although WMH have been mostly described in aging populations with cerebrovascular disease, extensive lesions also occur in non-vascular diseases. Such lesions are traditionally treated as a separate pathological entity from vascular ones, but recent work has challenged the appropriateness of that framework when probing WMH etiology. Comparing biomarkers associated with WMH across various pathologies may improve our understanding of their etiology.
Inclusion criteria: The review will focus on cerebrovascular disease and neurodegenerative disorders and exclude infectious, metabolic, drug-induced, or radiation-induced white matter diseases. Original, peer-reviewed research on the relationship of WMH on magnetic resonance imaging with blood/cerebrospinal fluid biomarkers will be considered for inclusion. Postmortem studies will guide the selection of biomarkers of interest and the interpretation of our findings. Genomic markers will be excluded.
Methods: The review will be conducted in accordance with PRISMA and JBI guidelines. English articles of interest published between 2000 and 2020 will be identified in MEDLINE and Embase. Two reviewers will perform abstract and full-text screening, standardized data extraction, and quality assessments of the selected studies. The relationship between each biomarker and WMH burden will be meta-analyzed, if possible, with subgroup or meta-regression analyses to assess differences between diseases.
Systematic review registration number: PROSPERO CRD42020218298.
Copyright © 2021 JBI.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts.Neuroimage Clin. 2022;36:103204. doi: 10.1016/j.nicl.2022.103204. Epub 2022 Sep 16. Neuroimage Clin. 2022. PMID: 36155321 Free PMC article.
-
White matter hyperintensities and cognition across different Alzheimer's biomarker profiles.J Am Geriatr Soc. 2021 Jul;69(7):1906-1915. doi: 10.1111/jgs.17173. Epub 2021 Apr 23. J Am Geriatr Soc. 2021. PMID: 33891712 Free PMC article.
-
Automatic segmentation of white matter hyperintensities: validation and comparison with state-of-the-art methods on both Multiple Sclerosis and elderly subjects.Neuroimage Clin. 2022;33:102940. doi: 10.1016/j.nicl.2022.102940. Epub 2022 Jan 10. Neuroimage Clin. 2022. PMID: 35051744 Free PMC article.
-
White Matter Hyperintensity as a Vascular Contribution to the AT(N) Framework.J Prev Alzheimers Dis. 2023;10(3):387-400. doi: 10.14283/jpad.2023.53. J Prev Alzheimers Dis. 2023. PMID: 37357280 Review.
-
White matter hyperintensities and geriatric syndrome: An important role of arterial stiffness.Geriatr Gerontol Int. 2015 Dec;15 Suppl 1:17-25. doi: 10.1111/ggi.12673. Geriatr Gerontol Int. 2015. PMID: 26671153 Review.
Cited by
-
The Blood-Cerebrospinal Fluid Barrier Dysfunction in Brain Disorders and Stroke: Why, How, What For?Neuromolecular Med. 2024 Sep 15;26(1):38. doi: 10.1007/s12017-024-08806-0. Neuromolecular Med. 2024. PMID: 39278883 Review.
References
-
- Tintore M, Rovira À, Río J, Otero-Romero S, Arrambide G, Tur C, et al. Defining high, medium and low impact prognostic factors for developing multiple sclerosis. Brain 2015; 138 (Pt 7):1863–1874.
-
- Debette S, Schilling S, Duperron M-G, Larsson SC, Markus HS. Clinical significance of magnetic resonance imaging markers of vascular brain injury: a systematic review and meta-analysis. JAMA Neurol 2019; 76 (1):81–94.
-
- Alber J, Alladi S, Bae H-J, Barton DA, Beckett LA, Bell JM, et al. White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): knowledge gaps and opportunities. Alzheimers Dement 2019; 5:107–117.
-
- McAleese KE, Walker L, Graham S, Moya ELJ, Johnson M, Erskine D, et al. Parietal white matter lesions in Alzheimer's disease are associated with cortical neurodegenerative pathology, but not with small vessel disease. Acta Neuropathol 2017; 134 (3):459–473.
-
- Woollacott IOC, Bocchetta M, Sudre CH, Ridha BH, Strand C, Courtney R, et al. Pathological correlates of white matter hyperintensities in a case of progranulin mutation associated frontotemporal dementia. Neurocase 2018; 24 (3):166–174.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources